The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Population pharmacokinetic (PK) analysis of TAS-102 in patients (pts) with metastatic colorectal cancer (mCRC): Results from 3 phase 1 trials and the phase 3 RECOURSE trial.
 
James M. Cleary
No Relationships to Disclose
 
Robert J. Mayer
Honoraria - Amgen; AstraZeneca
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Fumiaki Yamashita
Employment - Taiho Pharmaceutical
 
Kunihiro Yoshisue
Employment - Taiho Pharmaceutical
 
Ichiro Ieiri
No Relationships to Disclose
 
Atsushi Ohtsu
Employment - Celgene (I)
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Merck Serono; Taiho Pharmaceutical
 
Heinz-Josef Lenz
Honoraria - Bayer; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Celgene; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche